Results 231 to 240 of about 1,085,764 (289)

Percutaneous Reperfusion Therapies vs. Anticoagulation in Patients With Acute Intermediate-High-Risk Pulmonary Embolism: The PRETHA Randomized Clinical Trial. [PDF]

open access: yesPulm Circ
Ivanauskienė T   +9 more
europepmc   +1 more source

SPARCL1 and NT‐proBNP as biomarkers of right ventricular‐to‐pulmonary artery uncoupling in pulmonary hypertension

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1416-1426, April 2025.
Abstract Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH. The present study investigated whether NT‐proBNP and SPARCL1 concentrations are associated with load ...
Oliver Dörr   +15 more
wiley   +1 more source

Advanced Virtual Impedance for Power‐Sharing Improvement in Microgrids Using Different SOGI Methods: A Comparative Study

open access: yesEnergy Technology, EarlyView.
Advanced virtual impedance control integrating multiple second‐order generalized integrator (SOGI) variants—SOGI, ESOGI, MSOGI, and DSOGI—enhances power and harmonic sharing accuracy in islanded microgrids. The comparative study quantifies performance–complexity trade‐offs, demonstrating up to 65% total harmonic distortion (THD) reduction and improved ...
Camelia Ait Hammouda   +3 more
wiley   +1 more source

Elevated tricuspid peak systolic gradient with enlarged right ventricle present during acute episode of pulmonary embolism predict subsequent chronic thromboembolic pulmonary hypertension. [PDF]

open access: yesThromb J
Dzikowska-Diduch O   +10 more
europepmc   +1 more source

Longest survivor of pulmonary atresia with ventricular septal defect without surgical intervention

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1499-1507, April 2025.
Sang Zhou   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy